In this Issue:
Atrial tissue fibrosis associated with recurrent arrhythmia
Oral anticoagulant initiation before and after safety goals
High-sensitivity troponin-I for AF risk assessment
Dabigatran vs. warfarin in catheter ablation of AF
Role of LAA closure devices in long-term AF management
Dabigatran concentrations and ischaemic stroke/major bleeding in AF
Managing oral anticoagulants in AF with device surgery
Bleeding risk in AF without anticoagulants
NT-proBNP levels for predicting stroke in anticoagulated AF
Colchicine for recurrent AFprevention after PVI
Please login below to download this issue (PDF)